CHPA Offers OTC Testing, Degradant Standards For Monograph Modernization
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association looks to shape U.S. Pharmacopeia's revision of monographs for OTC drug ingredients and products with proposals for the standard-setting organization's monograph modernization process.
You may also be interested in...
In Brief: Acetaminophen Warnings, OTC HSA Bill, Durbin’s Supplement Reg Bill
FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.
In Brief: Acetaminophen Warnings, OTC HSA Bill, Durbin’s Supplement Reg Bill
FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.
USP Monograph Modernization Requires Flexibility For OTCs, Experts Agree
The U.S. Pharmacopeia monograph modernization initiative must take a flexible approach in order to accommodate formulation of complex OTC products, experts say.